Updated:
Navista
Navista operates as an alliance rather than an acquisition vehicle, launched by Cardinal Health to provide capital funding, centralized administrative...
Navista
Navista operates as an alliance rather than an acquisition vehicle, launched by Cardinal Health to provide capital funding, centralized administrative technology, and value-based care contracting to independent oncology practices. The model reflects a bet on the economic viability of community-based care against hospital-consolidation headwinds. Navista describes its footprint as multidisciplinary oncology and urology care delivered through more than 50 sites nationally, with a proposition centered on keeping community practices independent. The alliance provides member practices with AI-enabled workflow tools, revenue-cycle management, payer contracting strategies, and direct capital deployment for growth. Navista points to Dr. Dexter Estrada at cCARE as an example of a physician leveraging the platform to expand local treatment capabilities. The architecture is not a traditional GP/LP fund; it is a corporate-services bundle with embedded financial support, making it a balance-sheet operator within the broader Cardinal Health healthcare-supply ecosystem. Diana Verrilli, Navista's General Manager, joined Cardinal Health after 23 years at McKesson and The US Oncology Network, where she developed oncology care models and payer contracting frameworks. Chief Medical Officer Dr. Lalan Wilfong, a former Texas Oncology and Thyme Care executive, joined the firm in 2025 and is responsible for clinical leadership and value-based care advancement. The leadership team is a mix of Cardinal Health veterans and external hires from McKesson, CVS Health, and Thyme Care. Navista's structural distinction is that it does not seek to acquire practices outright but rather to align them contractually under a shared-services and technology umbrella, preserving a degree of physician independence that traditional roll-up models sacrifice. This makes the entity more akin to a managed-services organization with a captive capital-formation channel than a conventional family office or asset manager.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Nashville
Corporate office
Nashville, TN, United States
Principals
Diana Verrilli
General Manager
Lalan Wilfong, MD
Chief Medical Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Navista?
Navista is not structured as an investment fund; it operates as a corporate services alliance within Cardinal Health. Capital deployment decisions into member practices are made by the leadership team, led by General Manager Diana Verrilli and Vice President of Finance Steve Lin, who oversee the financial support and growth capital provided to alliance members.
Is Navista a single family office or a traditional investment firm?
Navista is neither. It is a corporate strategic initiative owned and operated by Cardinal Health, a publicly traded healthcare logistics and services company. The entity functions as an integrated practice-services organization, providing operational support, technology, and capital funding to independent oncology practices in return for exclusive alliance membership.
How does Navista source its capital for deploying into practices?
Capital for Navista's practice-support activities comes directly from Cardinal Health's corporate balance sheet. There is no external fundraising or third-party investor base. The capital allocation is internally governed and tied to Cardinal Health's strategic objective of securing downstream oncology distribution and services relationships.
What is Navista's known posture on co-investments alongside external GPs?
Navista does not participate in co-investment partnerships with external GPs. Its model is strictly a direct-services and capital-provision arrangement between the Cardinal Health corporate entity and the member oncology practices that join the alliance.
How is Navista related to Cardinal Health?
Navista is a fully owned and operated business unit of Cardinal Health. It was established to consolidate Cardinal Health's outreach to independent community oncology practices under a single branded alliance, leveraging the parent company's balance sheet, supply-chain infrastructure, and corporate administrative backbone.
What investment stages does Navista typically target?
Navista targets established independent oncology practices seeking growth capital, operational scale, and technological infrastructure to remain competitive. It does not invest in early-stage biotech, drug discovery, or pre-revenue healthcare startups. The focus is exclusively on maturing physician group practices capable of integrating into a value-based care and shared-services network.
Where does the underlying wealth come from?
Navista does not manage private family wealth. Its funding and strategic mandate derive entirely from its publicly traded parent company, Cardinal Health, whose primary business is pharmaceutical distribution, medical product manufacturing, and healthcare logistics.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: